Blood pressure-lowering efficacy of an olmesartan medoxomil/ hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: Subgroup analysis of a 12-week, open-label, single-arm, dose-titration study

Drugs and Aging

Volumn 28, Issue 6, 2011, Pages 477-490

  Neutel, Joel ^a   Kereiakes, Dean J ^b   Stoakes, Kathy A ^c   Maa, Jen Fue ^c   Shojaee, Ali ^c   Waverczak, William F ^c  

^a Orange County Research Center   (United States)

^b The Carl & Edyth Lindner Center for Research & Education   (United States)

^c DAIICHI SANKYO INC   (United States)

Author keywords

Elderly; Hydrochlorothiazide; Hypertension; Olmesartan medoxomil; Olmesartan medoxomilhydrochlorothiazide

Indexed keywords

HYDROCHLOROTHIAZIDE; OLMESARTAN;

AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; ELDERLY CARE; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; AMBULATORY CARE; BLOOD PRESSURE; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; IMIDAZOLES; MALE; SEX DISTRIBUTION; TETRAZOLES;

EID: 79958269219     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11589460-000000000-00000     Document Type: Article

References (37)

1. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008 May 3; 371 (9623): 1513-8
2. Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002 Feb 27; 287 (8): 1003-10 (Pubitemid 34252058)
3. Weber MA. Outcomes of treating hypertension in the elderly: a short commentary on current issues. Am J Geriatr Cardiol 2003 Jan-Feb; 12 (1): 14-8
4. Beckett NS, Peters R, Fletcher AE, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008 May 1; 358 (18): 1887-98 (Pubitemid 351620109)
5. Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ 2008 May 17; 336 (7653): 1121-3 (Pubitemid 351731743)
6. Kassai B, Boissel JP, Cucherat M, et al. Treatment of high blood pressure and gain in event-free life expectancy. Vasc Health Risk Manag 2005; 1 (2): 163-9
7. Duprez DA. Systolic hypertension in the elderly: addressing an unmet need. Am J Med 2008 Mar; 121 (3): 179-84, e3
8. Franklin SS, Jacobs MJ, Wong ND, et al. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension 2001 Mar; 37 (3): 869-74 (Pubitemid 32221606)
9. Williams B, Lindholm LH, Sever P. Systolic pressure is all that matters. Lancet 2008 Jun 28; 371 (9631): 2219-21
10. Obisesan TO, Obisesan OA, Martins S, et al. High blood pressure, hypertension, and high pulse pressure are associated with poorer cognitive function in persons aged 60 and older: the Third National Health and Nutrition Examination Survey. J Am Geriatr Soc 2008 Mar; 56 (3): 501-9 (Pubitemid 351327944)
11. Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002 Nov-Dec; 4 (6): 393-404 (Pubitemid 35469393)
12. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998 Jun 13; 351 (9118): 1755-62 (Pubitemid 28269185)
13. Neutel JM, Gilderman LI. Hypertension control in the elderly. J Clin Hypertens (Greenwich) 2008 Jan; 10 (1 Suppl. 1): 33-9
14. Okonofua EC, Simpson KN, Jesri A, et al. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension 2006 Mar; 47 (3): 345-51 (Pubitemid 43740273)
15. Kereiakes DJ, Neutel J, Stoakes KA, et al. The effects of an olmesartan medoxomil-based treatment algorithm on 24-hour blood pressure levels in elderly patients aged 65 and older. J Clin Hypertens (Greenwich) 2009 Aug; 11 (8): 411-21
16. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics, 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008 Jan 29; 117 (4): e25-146
17. Richardson AD, Piepho RW. Effect of race on hypertension and antihypertensive therapy. Int J Clin Pharmacol Ther 2000 Feb; 38 (2): 75-9 (Pubitemid 30077982)
18. Jamerson K, DeQuattro V. The impact of ethnicity on response to antihypertensive therapy.AmJMed 1996 Sep 30; 101 (3A): 22S-32S
19. Park IU, Taylor AL. Race and ethnicity in trials of antihypertensive therapy to prevent cardiovascular outcomes: a systematic review. Ann Fam Med 2007 Sep-Oct; 5 (5): 444-52 (Pubitemid 47535976)
20. Wassertheil-Smoller S, Psaty B, Greenland P, et al. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA 2004 Dec 15; 292 (23): 2849-59 (Pubitemid 39628232)
21. Noon JP, Trischuk TC, Gaucher SA, et al. The effect of age and gender on arterial stiffness in healthy Caucasian Canadians. J Clin Nurs 2008 Sep; 17 (17): 2311-7
22. O?Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007 Jul 3; 50 (1): 1-13 (Pubitemid 46963521)
23. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressuremeasurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005 Feb 8; 111 (5): 697-716 (Pubitemid 40216499)
24. Pickering TG, White WB. ASH Position Paper: home and ambulatory blood pressure monitoring. When and how to use self (home) and ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich) 2008 Nov; 10 (11): 850-5
25. Campbell NR, Khan NA, Hill MD, et al. 2009 Canadian Hypertension Education Program recommendations: the scientific summary - an annual update. Can J Cardiol 2009 May; 25 (5): 271-7
26. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003 Dec; 42 (6): 1206-52 (Pubitemid 37553153)
27. Izzo Jr JL, Neutel JM, Silfani T, et al. Efficacy and safety of treating stage 2 systolic hypertension with olmesartan and olmesartan/HCTZ: results of an open-label titration study. J Clin Hypertens (Greenwich) 2007 Jan; 9 (1): 36-44
28. Kereiakes DJ, Neutel JM, Punzi HA, et al. Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate. Am J Cardiovasc Drugs 2007; 7 (5): 361-72 (Pubitemid 47624540)
29. Benicar HCT (olmesartan medoxomil-hydrochlorothiazide tablets): US prescribing information. Parsippany (NJ): Daiichi Sankyo, Inc., 2007
30. Hertz RP, Unger AN, Cornell JA, et al. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med 2005 Oct 10; 165 (18): 2098-104 (Pubitemid 41434584)
31. Ferdinand KC, Armani AM. The management of hypertension in African Americans. Crit Pathw Cardiol 2007 Jun; 6 (2): 67-71 (Pubitemid 46878235)
32. Appel L, Robinson K, Guallar E. Utility of blood pressure monitoring outside of the clinic setting. Evidence Report/Technology Assessment No. 63 (prepared by the Johns Hopkins Evidence-based Practice Center under Contract No. 290-97-006). Rockville (MD): Agency for Healthcare Research and Quality, 2002
33. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003 Mar 18; 107 (10): 1401-6 (Pubitemid 36350739)
34. Burr ML, Dolan E, O?Brien EW, et al. The value of ambulatory blood pressure in older adults: the Dublin outcome study. Age Ageing 2008 Mar; 37 (2): 201-6 (Pubitemid 351445192)
35. Staessen JA, Asmar R, De Buyzere M, et al. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit 2001 Dec; 6 (6): 355-70 (Pubitemid 34194893)
36. Pickering TG, Shimbo D, Haas D. Ambulatory bloodpressure monitoring. N Engl J Med 2006 Jun 1; 354 (22): 2368-74
37. Palatini P, Dorigatti F, Mugellini A, et al. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Clin Ther 2004 Sep; 26 (9): 1436-45 (Pubitemid 39572157)